N ANTISERUM TO C1 INHIBITOR— 510(k) K960257

Name: FDA 510(k) clearance K960257
Creator: U.S. Food and Drug Administration
Published: 1996-08-01

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K960257 for N ANTISERUM TO C1 INHIBITOR, Substantially Equivalent on 1996-08-01. Applicant: Behring Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code DBA
Device class: Class 2
Regulation: 21 CFR 866.5250
Advisory panel: Immunology
Date received: 1996-01-18
Decision date: 1996-08-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westwood, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DBA

view all

K141100 — OPTILITE C1 INACTIVATOR KIT2014-07-18
K122304 — HUMAN C1 INACTIVATOR KIT FOR USE ON SPAPLUS2013-04-15
K072965 — DIMENSION VISTA C1 IN; FLEX REAGENT CARTRIDGE, CAL, CON2007-12-21
K011780 — K-ASSAY C1-INA2001-07-25
K003747 — C1-INHIBITOR MICROTITER ASSAY DEVICE2001-03-19

More clearances from Behring Diagnostics, Inc.

view all

K973832 — OPUS HLH CONTROLS1997-10-27
K972929 — N ANTISERUM TO HUMAN ALBUMIN1997-10-20
K972840 — N ANTISERUM TO HUMAN TRANSFERRIN1997-10-17
K973202 — MODIFICATION OF OPUS FERRITIN TEST SYSTEM1997-09-12
K972316 — OPUS D-DIMER1997-09-09

Data sourced from openFDA. This site is unofficial and independent of the FDA.